The Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences degree programs emphasize independent research that focuses on the in-depth study of a pharmacological or pharmaceutical problem in each student's chosen research specialty area. These degree programs allow students to master the skills necessary for careers in academia, industry and government.
Concentrations are available in four areas:
Medicinal Chemistry encompasses the search for, design of and synthesis of new drug entities, structural analysis of drugs, structure-activity relationships, interactions between drugs and molecular targets, natural product chemistry and aspects of drug metabolism.
Pharmaceutics emphasizes development of novel drug delivery methods, absorption, metabolism and drug formulations. Early course work provides a solid foundation in pharmaceutics, pharmacokinetics, physical pharmacy, dosage formulation and delivery systems. Areas of research interest include oral dosage formulations, transdermal and liposomal drug delivery, therapeutic DNA delivery, absorption and metabolism, and pharmacokinetics. Students in the Pharmaceutics Concentration may develop research programs in the areas of drug delivery systems, drug stability, dosage forms and pharmacokinetics.
Pharmacology emphasizes molecular and cellular aspects of pharmacological research to understand function at the cellular, organ and whole body level. Areas of research emphasis in the department include cardiovascular/renal pharmacology, cellular signalling and transport, traditional medicine and natural products, and neuropharmacology. Students in the Pharmacology Concentration may develop research programs in the areas of renal, autonomic, central nervous system, cardiovascular pharmacology, signal transduction, cellular physiology of exercise and aging, protein biochemistry or medicinal chemistry of natural products.
Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives. Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.
September 2025
College of Pharmacy
4849 Calhoun,
HOUSTON,
Texas,
77204, United States
Applicants to the Ph.D. program Concentrations in Pharmacology, Medicinal Chemistry and Pharmaceutics must have, or nearly have, at least a Bachelor s degree in pharmacy, biology, biochemistry, chemistry or a related discipline. In addition, applicants to the Pharmacology Concentration must have taken at least 3-credit hour course in human physiology and at least one 3-credit hour course in biochemistry. A minimum undergraduate (and graduate, if applicable) GPA of 3.0 on a 4-point scale is required. The average GPA of students admitted in 2018 and 2019 was 3.6.
Applicants to the Ph.D. program's Pharmaceutical Health Outcomes and Policy Concentration must have either completed or expect to complete a B.S. degree in a similar area with an overall GPA of 3.0 on a 4-point scale. The average GPA of students admitted in 2018 and 2019 was 3.6.
English Language Proficiency Requirements
TOEFL (Test of English as a Foreign Language)
The minimum TOEFL score required is 79 for the internet-based test. The minimum TOEFL score for the paper-based exam is 550.
IELTS (International English Language Testing Service)
The minimum IELTS score required is an overall score of a 6.5.
*There may be different IELTS requirements depending on your chosen course.